Conference Call with Divi's Laboratories Ltd. Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.
Pharmaceuticals company Divi's Laboratories announced Q1FY25 results: Financial Highlights: Divi's Laboratories has earned a total income Rs 2,197 crore for Q1FY25 on a consolidated basis as against an income of Rs 1,859 crore for the corresponding quarter of last year. Profit before Tax (PBT) for the current quarter amounted to Rs 604 crore as against a PBT of Rs 492 crore for the corresponding quarter of the last year and a PBT of Rs 713 crore for the fourth quarter of last year. The Company earned a Profit after Tax (PAT) of Rs 430 crore for the current quarter as against a PAT of Rs 356 crore for the corresponding quarter of the last year. PAT for the fourth quarter of last year was Rs 538 crore. Forex loss for the current quarter amounted to Rs 1 crore as against a gain of Rs 3 crore during the corresponding quarter of the last year. Result PDF